Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 22, 2023
The Difference Between Cystatin C- and Creatinine-Based Estimated GFR in Heart Failure With Reduced Ejection Fraction: Insights From PARADIGM-HFAlberto Pinsino, Matthew R Carey, Syed Husain, et al.
Clinical Transplantation|October 22, 2024
CAV Trajectories Among Patients With No or Mild CAV at 10 Years PosttransplantErin Harris, Nikil Prasad, Devin Skoll, et al.
JACC. Heart Failure|June 30, 2026
Impact of Age on Long-Term Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 TrialBoaz Elad, Jayant K Raikhelkar, Kevin J Clerkin, et al.
Artificial Organs|October 8, 2024
Anti-factor Xa and activated partial thromboplastin time strategies for unfractionated heparin dosing after HeartMate 3 left ventricular assist device implantationIris Feng, Paul A Kurlansky, Tanner R Powley, et al.
Clinical Transplantation|January 9, 2026
Heart Transplantation in Patients With Systemic SclerosisMorgan D Smith, Miroslav Sekulic, Matthew Regan, et al.
ESC Heart Failure|June 28, 2022
The difference between cystatin C- and creatinine-based assessment of kidney function in acute heart failureAlberto Pinsino, Matteo Fabbri, Lorenzo Braghieri, et al.
Journal of Cardiac Failure|May 14, 2021
Right Ventricular Pressure-Volume Analysis During Left Ventricular Assist Device Speed Optimization Studies: Insights Into Interventricular Interactions and Right Ventricular FailureMichael I Brener, Nadira B Hamid, Justin A Fried, et al.
Artificial Organs|June 3, 2024
Unplanned hospital readmissions following HeartMate 3 implantation: Readmission rates, causes, and impact on survivalHueyjong Shih, Giulio M Mondellini, Paul A Kurlansky, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 28, 2024
Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosingAlberto Pinsino, Douglas L Jennings, Annamaria Ladanyi, et al.
Pharmacotherapy|August 18, 2022
Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantationLorenzo Braghieri, Douglas L Jennings, Bruno Bohn, et al.
Pageof 8